证券代码：300492 证券简称：华图山鼎 华图山鼎设计股份有限公司 2025 年员工持股计划 本方案主要条款与公司 2025 年 4 月 29 日公告的员工持股计划草案及其摘要内容一致 华图山鼎设计股份有限公司 二○二五年五月 声明 本公司及董事会全体成员保证本持股计划内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 1 风险提示 1、华图山鼎设计股份有限公司（以下简称"华图山鼎"、"公司"或"本公司"） 2025年员工持股计划（以下简称"员工持股计划"、"本员工持股计划"）已获得股东 大会批准，具体资金来源、出资比例、实施方案等属初步结果，能否完成实施，存在不 确定性。 2、若员工认购资金不足，本持股计划存在低于预计规模的风险。 3、公司后续将根据规定披露相关进展情况，敬请广大投资者谨慎决策，注意投资 风险。 2 特别提示 1、华图山鼎设计股份有限公司（以下简称"华图山鼎"或"公司"）2025年员工持股计 划（以下简称"本持股计划"）系公司依据《中华人民共和国公司法》《中华人民共和国 证券法》《关于上市公司实施员工持股计划试点的指导意见》《深圳证券交易所上市公 司自律监管指引第2号——创业板上 ...

北京市竞天公诚律师事务所 关于华图山鼎设计股份有限公司 2024 年年度股东大会的 中国北京市朝阳区建国路 77 号华贸中心 3 号写字楼 34 层 邮政编码 100025 电话: (86-10) 5809-1000 传真: (86-10) 5809-1100 关于华图山鼎设计股份有限公司 2024 年年度股东大会的法律意见书 致：华图山鼎设计股份有限公司 北京市竞天公诚律师事务所（以下简称"本所"）受华图山鼎设计股份有 限公司（以下简称"公司"）的委托，根据和参照《中华人民共和国公司法》 （以下称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）和 中国证券监督管理委员会发布的《上市公司股东会规则》（以下称"《规 则》"）等有关规定，就公司召开的 2024 年年度股东大会（以下称"本次股东 大会"）的有关事宜，出具本法律意见书。 为了出具本法律意见书，本所审查了公司提供的有关本次股东大会的如下 文件的原件或复印件： 二○二五年五月三十日 法律意见书 中国 北京 1、现场出席本次股东大会的有关股东、股东授权代表、董事、监事及其他 有关人员的身份证明及/或授权委托书； 2、公司董事会向本次股东 ...

证券代码：300492 证券简称：华图山鼎 公告编号：2025-032 华图山鼎设计股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会未涉及变更前次股东大会决议。 一、会议召开和出席情况 （一）股东大会届次：2024 年年度股东大会 公司董事会以公告方式向全体股东发出召开 2024 年年度股东大会的通知，详见 2025 年 4 月 29 日公司在巨潮资讯网（www.cninfo.com.cn）刊登的《关于召开 2024 年年度股东大会 通知的公告》（公告编号：2025-026）。 （二）会议召集人：公司董事会 （三）会议主持人：董事长吴正杲先生 （四）会议召开时间： 1、现场会议时间：2025 年 5 月 30 日（星期五）14:00 2、网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 30 日交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证券交易所互联网 投票系 ...

Core Viewpoint - The former actual controller of Huatu Shanding, Che Lu, plans to reduce his stake in the company by up to 3%, potentially cashing out approximately 386 million yuan, indicating a trend of significant share reductions by the former controller amid concerns about the company's performance [2][5][10]. Group 1: Shareholding and Reduction Plans - Che Lu currently holds 16.53% of Huatu Shanding's shares, making him the second-largest shareholder [4][6]. - This planned reduction marks Che Lu's fourth attempt to cash out, with the latest reduction scheduled between June 19 and September 18, 2025 [4][6]. - The shares Che Lu intends to sell are sourced from shares acquired before the company's IPO and from capital reserve conversions [4]. Group 2: Financial Performance and Market Context - Huatu Shanding's core business includes non-degree training and architectural design, with non-degree training being the primary focus [3][10]. - The company has faced poor performance since its change of ownership in 2019, with a notable decline in revenue and profits until a recent recovery in 2024, where revenue increased by 1046.34% year-on-year [10][11]. - In the first quarter of 2024, the company reported a revenue of 828 million yuan and a net profit of 121 million yuan, marking significant growth compared to previous years [11]. Group 3: Historical Context and Ownership Changes - Huatu Shanding was formerly known as Shanding Design and underwent a change in control in 2019, leading to a significant ownership transfer and a rebranding to Huatu Shanding [6][7]. - The ownership transition involved a complex arrangement where Huatu Education's assets were effectively injected into Huatu Shanding, aiming to pivot the company's focus towards education [10][11]. - Che Lu has previously cashed out significant amounts, totaling nearly 800 million yuan through various share reductions since the company's ownership change [9].

Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

若采用集中竞价方式减持，在任意连续90日内，减持股份总数不超过1,404,864股，即不超过公司总股本 1.00%；若采用大宗交易方式减持，在任意连续90日内，减持股份总数不超过2,809,729股，即不超过公 司总股本2.00%。减持价格将根据减持时的二级市场价格确定，且不低于发行价（若期间公司发生资本 公积转增股本等事项，价格将相应调整）。 华图山鼎设计股份有限公司于2025年5月27日发布公告，持股16.53%的股东车璐计划减持公司股份。此 次减持计划引起市场关注，究竟车璐为何减持，对公司又会产生何种影响？ 减持计划详情 车璐持有华图山鼎23,224,498股股份，占公司总股本比例16.53%。其计划于公告披露之日（2025年5月 27日）起15个交易日后的三个月内（2025年6月19日至2025年9月18日），通过集中竞价和大宗交易方式 减持股份，合计不超过4,214,593股，占公司总股本比例3.00% 。 登录新浪财经APP 搜索【信披】查看更多考评等级 本次减持计划符合相关法律、法规及规范性文件的规定。不过，减持计划实施具有不确定性，车璐将根 据市场情况、公司股价情况等决定是否具体实施。 从公司 ...

证券代码：300492 证券简称：华图山鼎 公告编号：2025-031 信息披露义务人车璐保证向本公司提供的信息内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 持有本公司股份 23,224,498 股（占本公司总股本比例 16.53%）的股东车璐 计划于本公告披露之日起 15 个交易日后的三个月内(2025 年 6 月 19 日至 2025 年 9 月 18 日)以集中竞价方式、大宗交易方式减持本公司股份合计不超过 4,214,593 股（占本公司总股本比例 3.00%）。 (一) 股东名称：车璐 (二)股东持有股份的总数量 23,224,498 股，占公司总股本的比例为 16.53%。 (一)本次拟减持的原因、股份来源、数量、方式、占公司总股本的比例、 减持期间、价格区间等具体安排。 1、减持的原因：个人资金需求。 华图山鼎设计股份有限公司 关于持股 5%以上股东减持股份预披露公告 2、股份来源: 公司首次公开发行前取得的股份以及以资本公积金转增股 本取得的股份。 3、减持股份数量及比例: 减持本公司股份合计不超过 4,214 ...

证券代码：300492 证券简称：华图山鼎 公告编号：2025-030 华图山鼎设计股份有限公司 监事会关于公司 2025 年限制性股票激励计划 首次授予激励对象名单的公示情况说明及核查意见 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 华图山鼎设计股份有限公司（以下简称"公司"）于 2025 年 4 月 27 日召开 第五届董事会第三次会议和第五届监事会第三次会议审议通过了《关于公司 <2025 年限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2025 年限 制性股票激励计划实施考核管理办法>的议案》等议案。具体内容详见公司于 根据《上市公司股权激励管理办法》 （以下简称"《管理办法》"）、 和《华图山鼎设计股份有限公司章程》（以下简称"《公司章程》"）的相关规定， 公司对 2025 年限制性股票激励计划（以下简称"本激励计划"）首次授予激励对 象名单在公司内部进行了公示。公司监事会结合公示情况对拟授予激励对象进行 了核查，相关公示情况及核查情况如下： 一、公示情况及核查方式 （一）公示情况 励计划首次授予激励对象名单》，对激励对象的姓名及职务予 ...

证券代码：300492 证券简称：华图山鼎 公告编号：2025-030 华图山鼎设计股份有限公司 监事会关于公司 2025 年限制性股票激励计划 首次授予激励对象名单的公示情况说明及核查意见 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 华图山鼎设计股份有限公司（以下简称"公司"）于 2025 年 4 月 27 日召开 第五届董事会第三次会议和第五届监事会第三次会议审议通过了《关于公司 <2025 年限制性股票激励计划（草案）>及其摘要的议案》《关于公司<2025 年限 制性股票激励计划实施考核管理办法>的议案》等议案。具体内容详见公司于 2025 年 4 月 29 日在巨潮资讯网（www.cninfo.com.cn）上披露的相关公告。 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《深圳证券 交易所创业板股票上市规则》（以下简称"《上市规则》"）、《深圳证券交易所创业 板上市公司自律监管指南第 1 号——业务办理》（以下简称"《监管指南第 1 号》"） 和《华图山鼎设计股份有限公司章程》（以下简称"《公司章程》"）的相关规定， 公司对 20 ...

Core Viewpoint - The competitive ratio for the 2025 national civil service examination is approximately 65:1, reflecting the ongoing trend of increasing interest in civil service exams in China, which has significantly boosted the performance of companies like Huatu Shanding in the non-degree training sector [1][6]. Company Performance - In 2024, Huatu Shanding achieved a revenue of 2.833 billion yuan, marking a year-on-year increase of 1046.34%, with non-degree training contributing 98.54% of the total revenue [1][3]. - For the first quarter of this year, Huatu Shanding reported a revenue of 827 million yuan, a nearly 20% increase year-on-year, and a net profit of 121 million yuan, up nearly 70% [2][4]. - The company’s face-to-face training generated 2.467 billion yuan in revenue, while online training and other services accounted for 167 million yuan [5]. Market Dynamics - The number of candidates for the national civil service examination has reached 2.586 million, with a recruitment plan of 39,700 positions, indicating a growing demand for civil service exam training [6]. - The training market for civil service and related examinations is projected to reach 50.5 billion yuan by 2026, with specific segments for civil service, public institutions, and teacher qualification exams expected to grow at compound annual growth rates of 11%, 8%, and 14%, respectively [6][7]. Competitive Landscape - The civil service training market is characterized by oligopolistic competition, with Huatu Shanding, Zhonggong Education, and Fenbi holding significant market shares [8]. - Huatu Shanding's gross margin for non-degree training was 54.46%, slightly lower than Zhonggong Education's 59.66% and Fenbi's 57.9% [8]. Strategic Initiatives - The company has invested heavily in AI research and development, with R&D expenses reaching 199 million yuan in 2024 and 36 million yuan in the first quarter of this year, reflecting a year-on-year increase of 511.6% [9]. - Huatu Shanding has established a robust teacher and staff training system, which is considered a core competitive advantage in the civil service training sector [9].